These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3579833)

  • 1. Hypertonic saline mimics the effects of vasopressin on inhibitory avoidance in the rat.
    Lebrun C; Le Moal M; Dantzer R; Bloom FE; Koob GF
    Behav Neural Biol; 1987 Mar; 47(2):130-7. PubMed ID: 3579833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitation of inhibitory avoidance by hypertonic saline is reversed by a vasopressin and a nicotinic antagonist.
    Baratti CM; Faiman CP; de Erausquin GA
    Behav Neural Biol; 1989 May; 51(3):424-35. PubMed ID: 2525022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of effects of vasopressin (AVP) on inhibitory avoidance by a vasopressin antagonist peptide [dPtyr(Me)AVP].
    LeBrun CJ; Rigter H; Martinez JL; Koob GF; Le Moal M; Bloom FE
    Life Sci; 1984 Oct; 35(14):1505-12. PubMed ID: 6482669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine vasopressin and a vasopressin antagonist peptide: opposite effects on extinction of active avoidance in rats.
    Koob GF; Le Moal M; Gaffori O; Manning M; Sawyer WH; Rivier J; Bloom FE
    Regul Pept; 1981 Jun; 2(3):153-63. PubMed ID: 7255768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osmotic stress mimics effects of vasopressin on learned behaviour.
    Koob GF; Dantzer R; Rodriguez F; Bloom FE; Le Moal M
    Nature; 1985 Jun 27-Jul 3; 315(6022):750-2. PubMed ID: 4010780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of hypertonic saline in the conscious rat.
    Garcia-Estañ J; Carbonell LF; Garcia-Salom M; Salazar FJ; Quesada T
    Life Sci; 1989; 44(19):1343-50. PubMed ID: 2566102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressure.
    Lebrun C; Le Moal M; Koob GF; Bloom FE
    Regul Pept; 1985 Jun; 11(2):173-81. PubMed ID: 4035008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of aversive stimulus properties of vasopressin.
    Bluthé RM; Dantzer R; Mormède P; Le Moal M
    Psychopharmacology (Berl); 1985; 87(2):238-41. PubMed ID: 3931152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin antagonists block peripheral as well as central vasopressin receptors.
    De Wied D; Gaffori O; Van Ree JM; De Jong W
    Pharmacol Biochem Behav; 1984 Sep; 21(3):393-400. PubMed ID: 6093152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central injections of arginine vasopressin prolong extinction of active avoidance.
    Koob GF; Dantzer R; Bluthé RM; Lebrun C; Bloom FE; Le Moal M
    Peptides; 1986; 7(2):213-8. PubMed ID: 3737445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of ACTH4-10, DG-AVP, and DG-OXT on heart rate and passive avoidance behavior in rats.
    Wan R; Diamant M; de Jong W; de Wied D
    Physiol Behav; 1992 Mar; 51(3):507-13. PubMed ID: 1326112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-related influence of arginine-vasopressin on a passive avoidance behavior: effect of rearing conditions.
    Crine AF
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):379-84. PubMed ID: 6541358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional responses of the rat vasopressin gene to acute and repeated acute osmotic stress.
    Zemo DA; McCabe JT
    Neurosci Res; 2002 Sep; 44(1):45-50. PubMed ID: 12204292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vasopressin antagonist d(CH2)5Tyr(Et)VAVP on plasma arginine vasopressin level after osmotic stimulus.
    László FA; Laczi F; Janáky T; Baláspiri L
    Endocr Regul; 1991 Sep; 25(3):181-3. PubMed ID: 1764609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular effects of arginine vasopressin during fluid deprivation in the rat.
    Aisenbrey GA; Handelman WA; Arnold P; Manning M; Schrier RW
    J Clin Invest; 1981 Apr; 67(4):961-8. PubMed ID: 7204578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The vasopressin response to centrally administered hypertonic solutions in the conscious rat.
    Wells T; Forsling ML; Windle RJ
    J Physiol; 1990 Aug; 427():483-93. PubMed ID: 2120429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive avoidance behavior, vasopressin and the immune system. A link between avoidance latency and immune response.
    Croiset G; Heijnen CJ; de Wied D
    Neuroendocrinology; 1990 Feb; 51(2):156-61. PubMed ID: 2106096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal administrations of a vasopressin analog (DDAVP) and hypertonic saline enhance learning behavior in rats.
    Chen XF; Chen ZF; Liu RY; Du YC
    Peptides; 1988; 9(4):717-21. PubMed ID: 3226949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
    Manning M; Lammek B; Bankowski K; Seto J; Sawyer WH
    J Med Chem; 1985 Oct; 28(10):1485-91. PubMed ID: 4045923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can vasopressin alone act as an unconditioned stimulus to produce passive avoidance behaviour in rats in a typical memory experiment?
    Ebenezer IS
    Neuropharmacology; 1988 Sep; 27(9):903-7. PubMed ID: 3185866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.